ASP0367 (MA-0211)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ASP0367 (MA-0211), covering 2024-10-22 to 2024-10-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess the Safety, Tolerability and Preliminary Efficacy of ASP0367 (MA-0211) in Pediatric Male Participants With Duchenne Muscular Dystrophy (DMD) [Phase 1]